Am J Transplant, Volume 21, Suppl 3 Archives - Page 139 of 139 - ATC Abstracts

2021 American Transplant Congress
Higher Calcineurin Inhibitor Levels Associate with Graft Outcomes in Kidney Recipients with De Novo Donor-specific Antibodies of Either Hla Class I or II
M. Béland, S. De Serres
Nephrology, CHU de Québec- Université Laval, Québec, QC, Canada
*Purpose: The development of de novo anti-HLA donor specific antibodies (dnDSA) is associated with poorer outcomes in kidney transplant recipients. We and other previously reported…
2021 American Transplant Congress
Cancer Among Kidney Transplant Recipients More Than 20 Years After Transplantation: PTLD Remains the Most Common Cancer Type Even in the Very Long-Term
T. Schachtner, J. Fuhrmann, T. Mueller
Nephrology, University Hospital Zurich, Zurich, Switzerland
*Purpose: Due to an improved patient and kidney allograft survival, cancer is increasingly recognized as the major cause of death after kidney transplantation. Cancer risk…
2021 American Transplant Congress
Who Can be Matched via Kidney Exchange?
D. C. McElfresh¹, M. Curry², S. E. Booker³, D. Stewart³, M. Stuart³, R. Leishman⁴, T. Sandholm⁵, J. Dickerson²
¹Applied Mathematics, University of Maryland, College Park, MD, ²Computer Science, University of Maryland, College Park, MD, ³United Network for Organ Sharing, Seattle, WA, ⁴UNOS, Seattle, WA, ⁵Computer Science, Carnegie Mellon University, Pittsburgh, PA
*Purpose: Valuable time and resources are spent screening medically-compatible patients and donors for kidney exchange. Exchanges with tens or hundreds of patients can have thousands…
2021 American Transplant Congress
Chances of Renal Recovery in Liver Only Transplant Recipients Who Were Eligible for Simultaneous Liver-Kidney Transplant
J. Cui¹, A. Spann², A. Shingina², H. M. Schaefer³, J. C. Slaughter⁴, S. Alexopoulos⁵, M. Izzy²
¹Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, ²Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, TN, ³Nephrology, Vanderbilt University Medical Center, Nashville, TN, ⁴Biostatistics, Vanderbilt University Medical Center, Nashville, TN, ⁵Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Progressive decline in renal function is common among patients with end-stage liver disease. Liver transplant (LT) candidates can often develop severely impaired renal function…
2021 American Transplant Congress
Implementation of a High-risk Medication Report for Waitlisted Liver Transplant Candidates
M. M. Eiting¹, H. Yeh², M. Cote¹, S. Shao¹, A. B. Scherrer², L. Dageforde², N. Elias², C. Rogers Marks¹
¹Pharmacy, Massachusetts General Hospital, Boston, MA, ²Massachusetts General Hospital, Boston, MA
*Purpose: Use of high-risk medications (HRMs) at the time of liver transplant may lead to delays in surgery or peri-operative complications (bleeding, drug-drug interactions (DDI),…
2021 American Transplant Congress
Improving Liver Transplantation Outcomes for Hepatitis C Associated Hepatocellular Carcinoma in Direct-Acting Antiviral Therapy Era
K. Okumura, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. C. Wolf, S. Nishida
Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY
*Purpose: Direct-acting antiviral (DAA) therapy has transformed the outcomes of liver transplantation(LT) in patients with hepatitis C virus (HCV). The aim of this study was…
2021 American Transplant Congress
Comprehensive Intrahepatic Biliary Anatomy Underscores the Split-ability and the Origin of Biliary Leakage in Hemiliver Split Liver Transplant
J. Nguyen¹, K. Musto¹, M. Dougherty¹, R. Paz-Fugamalli², D. Harnois¹
¹Transplantation, Mayo Clinic Florida, Jacksonville, FL, ²Radiology, Mayo Clinic Florida, Jacksonville, FL
*Purpose: Hemiliver splitting is an effective approach to optimize the number of liver allografts available for both adult and pediatric patients on liver transplant waitlist.…
2021 American Transplant Congress
Long-term Outcomes of Donation After Cardiac Death and Living Donor Liver Transplant for Primary Sclerosing Cholangitis: An Analysis of UNOS Registry from 2002-2020
T. Kitajima, S. Nagai, T. Ivanics, T. Shamaa, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, D. Moonka
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Use of donation after circulatory death (DCD) grafts is a reported risk factor for worse outcomes after liver transplant (LT) for primary sclerosing cholangitis…
2021 American Transplant Congress
Immunologic Benefits of Maternal Living Donor Allografts in Pediatric Liver Transplantation: Less Rejection Episodes and No Evidence of De Novo Allosensitization
A. Barbetta¹, G. Meeberg², B. Rocque¹, S. Barhouma³, S. Gilmour⁴, F. Faytrouni⁵, O. Guttman⁵, P. Campbell⁴, J. Shapiro², J. Emamaullee¹
¹Surgery, Abdominal Transplant, University of Southern California, Los Angeles, CA, ²Surgery, University of Alberta, Edmonton, AB, Canada, ³University of Southern California, Los Angeles, CA, ⁴University of Alberta, Edmonton, AB, Canada, ⁵University of British Columbia, Vancouver, BC, Canada
*Purpose: Living donor liver transplantation (LDLT) offers improved graft and patient survival in pediatric liver transplant (LT) recipients. Prior studies have suggested immunological advantage when…